Literature DB >> 15956441

Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations.

Luisa Romanò1, Claudio Velati, Lorella Baruffi, Laura Fomiatti, Giuseppe Colucci, Alessandro R Zanetti.   

Abstract

We evaluated the COBAS Ampliscreen hepatitis B virus (HBV) test using standards, seroconversion panels, consecutive donations, and samples from patients with abnormal alanine aminotransferase and chronic hepatitis C. Specificity was 100% and sensitivity was 20 IU/ml. In seroconversion panels, HBV DNA was detected up to 4 to 18 days before HBsAg, suggesting that this assay is useful in shortening the infectious window phase.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15956441      PMCID： PMC1151896          DOI： 10.1128/JCM.43.6.2991-2993.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Current and emerging infectious risks of blood transfusions.

Authors:  Michael P Busch; Steven H Kleinman; George J Nemo
Journal:  JAMA       Date:  2003-02-26       Impact factor: 56.272

2.  Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

Authors:  Claudio Velati; Luisa Romanò; Lorella Baruffi; Marco Pappalettera; Vittorio Carreri; Alessandro R Zanetti
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

Review 3.  International application of the incidence rate/window period model.

Authors:  Simone A Glynn; Steven H Kleinman; David J Wright; Michael P Busch
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

4.  Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.

Authors:  Josiane Pillonel; Syria Laperche; Christine Saura; Jean-Claude Desenclos; Anne-Marie Couroucé
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

Review 5.  The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.

Authors:  S Kleinman; M P Busch; J J Korelitz; G B Schreiber
Journal:  Transfus Med Rev       Date:  1997-07

6.  Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood.

Authors:  R Sun; W Schilling; H Jayakar; J Ku; J Wang; M Rosenstraus; J Spadoro
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

7.  Estimated risk of transfusion-transmitted viral infections in Spain.

Authors:  Manuel Alvarez; Salvador Oyonarte; P M Rodríguez; J M Hernández
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

8.  Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.

Authors:  R Y Dodd; E P Notari; S L Stramer
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

9.  Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

Authors:  Clive R Seed; Anthea Cheng; Susan L Ismay; Wayne V Bolton; Philip Kiely; Trevor J Cobain; Anthony J Keller
Journal:  Transfusion       Date:  2002-10       Impact factor: 3.157

Review 10.  Transfusion risks of yesterday and of today.

Authors:  Jean-Pierre Allain
Journal:  Transfus Clin Biol       Date:  2003-02       Impact factor: 1.406
View more
  3 in total

1.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

2.  Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!

Authors:  R N Makroo; Mohit Chowdhry; Aakanksha Bhatia; Bhavna Arora; N L Rosamma
Journal:  Asian J Transfus Sci       Date:  2012-01

3.  Global epidemiology of occult hepatitis B virus infections in blood donors, a systematic review and meta-analysis.

Authors:  Guy Roussel Takuissu; Sebastien Kenmoe; Marie Amougou Atsama; Etienne Atenguena Okobalemba; Donatien Serge Mbaga; Jean Thierry Ebogo-Belobo; Arnol Bowo-Ngandji; Martin Gael Oyono; Jeannette Nina Magoudjou-Pekam; Ginette Irma Kame-Ngasse; Elisabeth Zeuko'o Menkem; Abdel Aziz Selly Ngaloumo; Agnès Thierry Rebecca Banlock; Alfloditte Flore Feudjio; Cromwel Zemnou-Tepap; Dowbiss Meta-Djomsi; Gilberte Louise Nyimbe Mviena; Ines Nyebe Eloundou; Jacqueline Félicité Yéngué; Josiane Kenfack-Zanguim; Juliette Laure Ndzie Ondigui; Ridole Martin Zekeng Mekontchou; Sabine Aimee Touangnou-Chamda; Yrene Kamtchueng Takeu; Jean Bosco Taya-Fokou; Chris Andre Mbongue Mikangue; Raoul Kenfack-Momo; Cyprien Kengne-Nde; Seraphine Nkie Esemu; Richard Njouom; Lucy Ndip
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.